MDxHealth is trading 12.86% down at $0.59 after closing at $0.67 on September 15, 2026, without a confirmed catalyst.

  • No company-specific announcement dated September 15 or September 16 was found on the company’s press-release page.
  • Broader markets are modestly higher ahead of the Federal Reserve decision, so market direction does not clearly explain the decline.
  • Earlier Nasdaq compliance notices remain stale context, not a confirmed cause.